ECG

This channel includes news and new technology innovations ECG, electrocardiogram systems. These systems are also referred to as EKG, or eletrokardiogram from the original German term, where ECG was first developed. The channel includes news on standard diagnostic ECG systems, ECG management systems, defibrillator-monitors, Holter technology, and remote and wearable ECG patient monitoring. 

There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.
News | ECG
Cardiac Insight Speaks Out Against Medicare Decision to Slash Reimbursement Rates and Limit Access to New ECG Technologies 

February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated ele ...

Home February 02, 2021
Home
HeartSciences has been developing a new type of ECG system called Wavelet ECG that may offer a new way of looking at the heart. The MyoVista system uses continuous wavelet transform (CWT) signal processing to provide new frequency and energy information to detect cardiac relaxation abnormalities associated with left ventricular diastolic dysfunction commonly associated with hypertension, diabetes, valvular disease, ischemia, and reduced systolic function. Artificial intelligence is used to read the exam.
Feature | ECG | By Dave Fornell, Editor
6 Trends In ECG Systems

Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems. The ...

Home January 20, 2021
Home
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Feature | Wearables
Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

Home December 15, 2020
Home
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.
News | Artificial Intelligence
FDA Clears First AI-Powered Algorithm Suite for Personal ECG Monitoring

November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive a ...

Home November 24, 2020
Home
Videos | Atrial Fibrillation
VIDEO: Screening for Atrial Fibrillation Using Single Lead ECG in the VITAL-AF Trial

Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking VITAL ...

Home November 18, 2020
Home
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.
News | Cardiac Diagnostics
Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum ...

Home October 06, 2020
Home
The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.
News | Implantable Cardiac Monitor (ICM)
Next Generation Medtronic ICM Offers Remote Programming and Improved Longevity

July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark ...

Home July 07, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: Why QT-prolongation Occurs in COVID-19 Patients on Hydroxychloroquine and Azithromycin

Interview with Andrew D. Krahn, M.D.,FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 28, 2020
Home
HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab
Frequent Coffee Consumption Lowers Chance of Arrhythmias

May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater risk ...

Home May 28, 2020
Home
WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19. #COVID19 #SARScov2 #Hydroxychloroquine
Feature | Coronavirus (COVID-19)
WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19

May 27, 2020 — Two of the front-line drugs being used to treat COVID-19 (SARS-CoV-2) patients are hydroxychloroquine and ...

Home May 27, 2020
Home
A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.
News | Artificial Intelligence
AI Tool Allows Automated ECG Interpretation for Cardiac Diagnostics

May 19, 2020 — Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to ...

Home May 19, 2020
Home
Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.
News | Wearables
Necklace Monitors ECG and Detects Abnormal Heart Rhythms

May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHR ...

Home May 08, 2020
Home
FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients. SARS-CoV-2 QT monitoring. #COVID19
News
FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients

May 5, 2020 — Wearable biosensor vendor VitalConnect Inc. was granted emergency use authorization (EUA) status by the U ...

Home May 05, 2020
Home
Cardiac Insight's Heart@Home ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor.
News | ECG Wireless Remote Access
Cardiac Insight Launches New Telehealth Solution for Cardiology Practices with [email protected] ECG Test Kit

May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor ...

Home May 04, 2020
Home
AliveCor and Omron are partnering to integrate Alivecor's mobile device ECG technology with Omron's wireless blood pressure monitoring technology on Remote Cardiovascular Monitoring into one platform for remote patient monitoring.
News | Remote Monitoring
AliveCor and Omron Partner on Remote Cardiovascular Monitoring

April 24, 2020 — AliveCor and Omron Healthcare announced a global, strategic alliance that combines AliveCor's mobile ...

Home April 24, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now